Azvudine Recruiting Phase 2 / 3 Trials for Coronavirus Disease 2019 (COVID‑19) Prevention

IndicationsStatusPurposePhase
RecruitingPrevention2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT05682599Evaluate Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 in China